-
Forward Look
Common-Sense ScreeningSigmoidoscopy may be a good option for colorectal cancer screening.
by Sue Rochman
-
Forward Look
Task Force Says “No” to PSA for Prostate Cancer ScreeningExpert panel's recommendation spurs debate.
by Stephen Ornes
-
A Genetic LegacyDoctors now know more than ever about the inherited cancer-related mutations that can link generations of family members. But with the new knowledge from scientific advances and DNA testing come new questions for patients.
by Sue Rochman
-
Forward Look
Healthy Lifestyle, Healthier ChromosomesQ&A with Elizabeth Blackburn, professor of biochemistry and physiology at the University of California, San Francisco.
by Rabiya Tuma
-
-
Forward Look
An Aspirin a Day …A link between the popular remedy and cancer prevention needs to be borne out in clinical trials.
by Stephen Ornes
-
Forward Look
A Diabetes Drug for Cancer?Lab results spur researchers to test low-cost medication on humans.
by Stephen Ornes
-
Forward Look
The Dense Breast DebateSome states are mandating that doctors tell patients about breast density, which can affect cancer risk.
by Mitzi Baker
-
The Family Cancer TreeAccurate reporting of family histories could be key to risk reduction.
by Mitzi Baker
-
The Survival GapIn the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
